Table 2.
Study flowchart.
| Study procedures | Screening | Care and follow-up | Follow-up until 240 minutes after treatment |
| Informed consent | ✓ |
|
|
| Eligibility criteria (without pain assessment) | ✓ |
|
|
| Demographics | ✓ |
|
|
| History and management of endometriosis | ✓ |
|
|
| Typology of pain crises | ✓ |
|
|
| Baseline pain assessment (T0) (just before the start of Endocare or control treatment) |
|
✓ |
|
| Assessment of general status | ✓ | ✓ | ✓ |
| Endocare or control treatment |
|
✓ |
|
| Pain evolution (pain relief and intensity) |
|
✓a | ✓b |
| Satisfaction |
|
|
✓b |
| Concomitant treatments |
|
✓c | ✓c |
| Adverse events |
|
✓ | ✓ |
aEvaluation 15 minutes (T15), 30 minutes (T30), 45 minutes (T45), and 60 (T60) minutes posttreatment.
bEvaluation 240 minutes (T240) posttreatment.
cIncludes rescue treatment if needed.